GHISLAINE TONYE: Open Payments
NPI 1679160949 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 17 payments from 10 companies in 2025. Trend: 2023 $288 · 2024 $483 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $124 |
| Corium, LLC | 6 | $93 |
| CeQur Corporation | 1 | $88 |
| Tempus AI, Inc | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Mannkind Corporation | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
Products named: REXULTI, Azstarys, CeQur Simplicity, TEMPUS PIXEL, Auvelity, REZDIFFRA, Kerendia, CAPLYTA.
Industry payments across IL — which companies pay providers there.
